25-05-2025
Jefferies Remains a Buy on Emcure Pharmaceuticals Limited (EMCURE)
In a report released on May 23, Alok Dalal from Jefferies maintained a Buy rating on Emcure Pharmaceuticals Limited (EMCURE – Research Report), with a price target of INR1,400.00. The company's shares closed last Friday at INR1,288.65.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Dalal is ranked #4967 out of 9536 analysts.
The analyst consensus on Emcure Pharmaceuticals Limited is currently a Hold rating.
The company has a one-year high of INR1,577.50 and a one-year low of INR890.00. Currently, Emcure Pharmaceuticals Limited has an average volume of 29.65K.
